EAST-ASIA PHARMACEUTICAL
60517715.653.64% ( +0.55 )
EAST-ASIA PHARMACEUTICAL (605177)
Zhejiang East Asia Pharmaceutical Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and...
- Open
- 15.26
- High
- 15.72
- Low
- 15.19
- Prev. Close
- 15.10
- Volume
- 19.00K
- Turnover
- 29.57M
- Avg Price
- 15.57
- Bid/Ask Ratio
- 31.36%
- Amplitude
- 3.51%
- 52wk High
- 24.70
- Volume Ratio
- 0.60
- Turnover Ratio
- 1.67%
EAST-ASIA PHARMACEUTICAL Analyst Rating
View MoreForecast & Rating
May 20, 2024Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 30, 2025 at 09:22 AM
EAST-ASIA PHARMACEUTICAL released its performance for the first three quarters, with a net loss attributable to the parent company of 72.41 million yuan
- Wallstreetcn · Oct 22, 2025 at 05:56 AM
The Shanghai Stock Exchange issued regulatory warnings to EAST-ASIA PHARMACEUTICAL and relevant responsible persons
- Zhitong · Aug 24, 2025 at 06:28 PM
Overview of A-share Stock Buybacks: Today, 4 Companies Disclosed Buyback Progress
- Zhitong · Jul 4, 2025 at 03:15 AM
EAST-ASIA PHARMACEUTICAL: Subsidiary obtains CNAS laboratory accreditation certificate
- Zhitong · Jun 13, 2025 at 03:44 AM
EAST-ASIA PHARMACEUTICAL: Levofloxacin Tablets Approved for Drug Registration Certificate
- Zhitong · May 15, 2025 at 02:35 AM
EAST-ASIA PHARMACEUTICAL: Quetiapine raw materials have obtained the raw material drug registration certificate in South Korea
